Sigrid enters strategic partnership with GetHealthy to meet growing demand in the US for Glucose Stabiliser as a non-pharmaceutical solution to control blood sugar levels

Stockholm, September 2, 2024: Sigrid Therapeutics today announced the signing of a strategic partnership with GetHealthy.store, a leading US provider of e-commerce solutions for healthcare providers selling healthcare and nutritional products. The partnership aims to meet the growing demand for Sigrid’s Glucose Stabiliser, a product that offers a groundbreaking non-pharmaceutical solution for controlling blood sugar levels. Glucose Stabiliser, which was trial-launched in Florida earlier this year, is already loved by thousands of individuals, with users reporting reduced bloating, increased energy levels and other significant health benefits – without any loss of muscle mass. Similar successes have also been noted in the Nordics and the UK.

Glucose Stabiliser capsules work by using Sigrid's patented SiPore® silica to slow down the breakdown of carbohydrates. Silica is a natural GRAS [2] certified material. Glucose Stabiliser taken orally before meals thus provides an effective non-pharmaceutical reduction of blood sugar spikes.

GetHealthy provides physicians with a complete 360° e-commerce solution based on an online storefront including product listings, escript protocols and educational materials backed by marketing support and warehousing and distribution. The company has established a leading position in the US dietary supplement market with customers reporting up to 150% year-over-year sales increases.

Jon Armstrong, CEO of GetHealthy, sees huge potential for Glucose Stabiliser: " We are very excited to enter into this partnership with Sigrid to offer Glucose Stabiliser to our extensive functional medicine network. We see it as a real game changer and have already received incredibly positive feedback from the market. The strong scientific basis, safety profile, efficacy and ease of use make Glucose Stabiliser an ideal product for our clients to sell via the practice-owned e-commerce platforms that we provide."

Sana Alajmovic, CEO of Sigrid Therapeutics, says: " We were immediately impressed by the professionalism of Jon and the GetHealthy team and how their ambitions harmonized with Sigrid's vision. We are confident that this partnership with the US leading e-commerce solutions provider will enable Glucose Stabiliser to reach its full potential and thereby make a lasting difference in the quality of life for people seeking safe and sustainable methods to control their blood sugar. This applies not only to already diagnosed type 2 diabetics and patients with impaired glucose tolerance, but also to pre-diabetics and people with weight problems ."

Prof. Tore Bengtsson , CSO at Sigrid Therapeutics adds: "Glucose Stabiliser with its SiPore® technology offers a unique non-pharmaceutical alternative to injectables for sustainable blood sugar control, suppressed hunger and reduced bloating . We are pleased that Glucose Stabiliser can provide a gentler and safer way to achieve sustainable weight control without negative effects on muscle mass. For patients who discontinue treatment with injectables, Glucose Stabiliser can be a way to prevent the usual weight gain that follows after stopping such treatments."